Wanbangde Pharmaceutical Holding Group Co., Ltd. (SHE:002082)
China · Delayed Price · Currency is CNY 15.74
+0.14 (0.90%)
Feb 3, 2026, 3:04 PM CST
SHE:002082 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | 14.2 | 55.44 | 49.21 | 93.26 | 166.51 | 284.94 |
Depreciation & Amortization | 98.7 | 98.7 | 96.94 | 107.03 | 94.98 | 107.11 |
Other Amortization | 8.35 | 8.35 | 1.71 | 1.2 | 1.24 | 5.11 |
Loss (Gain) From Sale of Assets | -15.74 | -15.74 | -0.12 | 0.95 | 1.21 | 0.31 |
Asset Writedown & Restructuring Costs | 21.75 | 21.75 | 2.88 | 90.27 | 47.37 | 76.36 |
Loss (Gain) From Sale of Investments | -20.23 | -20.23 | -0.66 | 0.06 | -229.65 | -13.17 |
Provision & Write-off of Bad Debts | -0.9 | -0.9 | 23.56 | 38.98 | 52.25 | 19.4 |
Other Operating Activities | -24.69 | 33.73 | 31.86 | 18.16 | 51.07 | 77.1 |
Change in Accounts Receivable | 12.88 | 12.88 | -15.2 | -101.79 | 178.83 | -626.94 |
Change in Inventory | 54.58 | 54.58 | 20.81 | -18.71 | 64.52 | -64.78 |
Change in Accounts Payable | -110.89 | -110.89 | -262.25 | -438.51 | -390.96 | 309.05 |
Operating Cash Flow | 20.57 | 120.22 | -72.87 | -239.65 | 22.09 | 151.01 |
Operating Cash Flow Growth | -90.11% | - | - | - | -85.38% | - |
Capital Expenditures | -278.83 | -97.11 | -128.72 | -167.23 | -285.51 | -559.24 |
Sale of Property, Plant & Equipment | 11.82 | 49.45 | 0.2 | 4.3 | 0.27 | 1.34 |
Cash Acquisitions | -10.54 | -10.54 | - | - | - | -79.9 |
Divestitures | 10 | - | - | - | 1,293 | - |
Sale (Purchase) of Intangibles | - | - | - | -4.96 | -13.1 | - |
Investment in Securities | -77.6 | -79.26 | - | - | - | -39.8 |
Other Investing Activities | 90.05 | -23.12 | 8.45 | -1.15 | 5.07 | -3.04 |
Investing Cash Flow | -247.02 | -152.49 | -156.03 | -167.42 | 999.46 | -680.64 |
Long-Term Debt Issued | - | 1,083 | 875.92 | 720.22 | 581.49 | 1,629 |
Total Debt Issued | 1,030 | 1,083 | 875.92 | 720.22 | 581.49 | 1,629 |
Long-Term Debt Repaid | - | -1,032 | -764.53 | -712.42 | -1,014 | -1,271 |
Total Debt Repaid | -1,052 | -1,032 | -764.53 | -712.42 | -1,014 | -1,271 |
Net Debt Issued (Repaid) | -22.83 | 50.72 | 111.39 | 7.8 | -432.13 | 358.02 |
Repurchase of Common Stock | - | - | - | -9.03 | -50.96 | - |
Common Dividends Paid | -36.84 | -90.84 | -122.03 | -43.91 | -191.66 | -170.77 |
Other Financing Activities | 283.61 | -2.21 | 19.89 | -17.93 | - | 252.36 |
Financing Cash Flow | 223.94 | -42.33 | 9.26 | -63.07 | -674.75 | 439.61 |
Foreign Exchange Rate Adjustments | 0.12 | -0.16 | -1.25 | 2.02 | -5.44 | 2.94 |
Net Cash Flow | -2.4 | -74.76 | -220.89 | -468.11 | 341.35 | -87.09 |
Free Cash Flow | -258.26 | 23.11 | -201.59 | -406.88 | -263.42 | -408.24 |
Free Cash Flow Margin | -18.63% | 1.60% | -13.07% | -22.78% | -13.64% | -2.98% |
Free Cash Flow Per Share | -0.53 | 0.04 | -0.33 | -0.65 | -0.43 | -0.67 |
Cash Income Tax Paid | 83.71 | 120.89 | 133.12 | 402.31 | 175.69 | 192.92 |
Levered Free Cash Flow | -186.3 | 55.23 | 44.08 | -373.4 | 800.46 | -340.2 |
Unlevered Free Cash Flow | -162.94 | 79.3 | 73.13 | -352.66 | 822.72 | -304.77 |
Change in Working Capital | -60.88 | -60.88 | -278.24 | -589.57 | -162.88 | -406.15 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.